| Dr Thomas W Brown Iii, MD | |
|
2707 Citico Ave, Chattanooga, TN 37406-3402 | |
| (423) 624-8588 | |
| (423) 622-3069 |
| Full Name | Dr Thomas W Brown Iii |
|---|---|
| Gender | Male |
| Speciality | Orthopedic Surgery |
| Experience | 41 Years |
| Location | 2707 Citico Ave, Chattanooga, Tennessee |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1932164209 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207X00000X | Orthopaedic Surgery | MD0000020236 (Tennessee) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Memorial Healthcare System, Inc | Chattanooga, TN | Hospital |
| Parkridge Medical Center | Chattanooga, TN | Hospital |
| Entity Name | Thomas W Brown Iii Md Pc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1386818649 PECOS PAC ID: 8921046756 Enrollment ID: O20050421000539 |
News Archive
​Researchers at the UNC School of Medicine have devised a new biochemical technique that will allow them and other scientists to delve much deeper than ever before into the specific cellular circuitry that keeps us healthy or causes disease.
Physician experts from the American College of Gastroenterology have released an updated educational monograph highlighting the unique clinical challenges of caring for women with chronic digestive disorders during pregnancy and managing GI complications relating to pregnancy.
Bavarian Nordic A/S announced today that the company has received a letter of concurrence from the U.S. Food and Drug Administration on a Special Protocol Assessment for a Phase 3 study required for product registration for its product candidate, PROSTVAC, for the treatment of patients with asymptomatic or minimally symptomatic metastatic castration-resistant prostate cancer.
Combining a histone deacetylase inhibitor drug with immunotherapy agents is safe, and may benefit some patients with advanced cancers that have not responded to traditional therapy, according to results of a phase 1 clinical trial led by researchers at the Johns Hopkins Kimmel Cancer Center, Bloomberg~Kimmel Institute for Cancer Immunotherapy and several other centers including University of Pittsburgh Cancer Institute, Yale Cancer Center and City of Hope in Los Angeles, which participated in study enrollment, and the University of Southern California and University College Cork in Ireland, which collaborated on analysis of the data.
› Verified 1 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Thomas W Brown Iii, MD 2707 Citico Ave, Chattanooga, TN 37406-3402 Ph: (423) 624-8588 | Dr Thomas W Brown Iii, MD 2707 Citico Ave, Chattanooga, TN 37406-3402 Ph: (423) 624-8588 |
News Archive
​Researchers at the UNC School of Medicine have devised a new biochemical technique that will allow them and other scientists to delve much deeper than ever before into the specific cellular circuitry that keeps us healthy or causes disease.
Physician experts from the American College of Gastroenterology have released an updated educational monograph highlighting the unique clinical challenges of caring for women with chronic digestive disorders during pregnancy and managing GI complications relating to pregnancy.
Bavarian Nordic A/S announced today that the company has received a letter of concurrence from the U.S. Food and Drug Administration on a Special Protocol Assessment for a Phase 3 study required for product registration for its product candidate, PROSTVAC, for the treatment of patients with asymptomatic or minimally symptomatic metastatic castration-resistant prostate cancer.
Combining a histone deacetylase inhibitor drug with immunotherapy agents is safe, and may benefit some patients with advanced cancers that have not responded to traditional therapy, according to results of a phase 1 clinical trial led by researchers at the Johns Hopkins Kimmel Cancer Center, Bloomberg~Kimmel Institute for Cancer Immunotherapy and several other centers including University of Pittsburgh Cancer Institute, Yale Cancer Center and City of Hope in Los Angeles, which participated in study enrollment, and the University of Southern California and University College Cork in Ireland, which collaborated on analysis of the data.
› Verified 1 days ago
Eric Peter Clarke, MD Orthopedic Surgery Medicare: Accepting Medicare Assignments Practice Location: 2707 Citico Avenue, Chattanooga, TN 37406 Phone: 423-624-8588 Fax: 423-622-3069 | |
Julie Elizabeth Adams, M.D. Orthopedic Surgery Medicare: Accepting Medicare Assignments Practice Location: 979 E 3rd St Ste C225, Chattanooga, TN 37403 Phone: 423-778-5995 Fax: 423-778-5994 | |
Dr. J Paul Martz, D.O. Orthopedic Surgery Medicare: Medicare Enrolled Practice Location: 2415 Mccallie Ave, Chattanooga, TN 37404 Phone: 423-624-2696 Fax: 423-697-2055 | |
Fred Barry Hodges Iii, MD Orthopedic Surgery Medicare: Not Enrolled in Medicare Practice Location: 979 E 3rd St, Ste C-220, Chattanooga, TN 37403 Phone: 423-267-4585 Fax: 423-265-4098 | |
Dr. Jeremy Reginald Bruce, MD Orthopedic Surgery Medicare: Accepting Medicare Assignments Practice Location: 975 E 3rd St, Chattanooga, TN 37403 Phone: 423-877-9297 | |
Dr. James Patterson Stone, M.D. Orthopedic Surgery Medicare: Not Enrolled in Medicare Practice Location: 2415 Mccallie Ave, Chattanooga, TN 37404 Phone: 423-624-2696 Fax: 423-697-2055 | |
Dr. Adam M Caputo, MD Orthopedic Surgery Medicare: Accepting Medicare Assignments Practice Location: 1736 Gunbarrel Rd, Chattanooga, TN 37421 Phone: 423-756-6623 |